ACTINIUM PHARMACEUTICALS
Actinium Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing therapies for life threatening diseases using its alpha particle immunotherapy platform and other related technologies. The company’s principal product candidates include Actimab-A, a Phase I/II clinical trial monoclonal antibody for the treatment of acute myeloid leukemia in elderly patients; and Iomab-B that has completed a Phase I/II design trial used to condition the bone marrow of patients by destroying blood cancer cells in their bone marrow. It also offers BC8-Y-90 and BC8-SA product candidates, which are in physician sponsored clinical phase I trials at the Fred Hutchinson Cancer Research Center. The company was founded in 2000 and is based in New York, New York.
ACTINIUM PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2000-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.actiniumpharmaceuticals.com
Total Employee:
11+
Status:
Active
Contact:
646-459-4201
Total Funding:
106.13 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Analytics IPv6 ReCAPTCHA Google Universal Analytics CrUX Top 50m ReCAPTCHA V2
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Alchemab Therapeutics
Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Constellation Pharmaceuticals
Constellation Pharmaceuticals develops drugs in the field of epigenetics focusing on selective regulators of its function.
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals focuses on improving kinase inhibitor treatments.
Marina Biotech
Patient Centric Care for Hypertension and Pain
Oramed Pharmaceuticals
Oramed Pharmaceuticals develops proprietary Protein Oral Delivery technology for the delivery of drugs.
Ra Pharmaceuticals
Ra Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules.
Current Advisors List
Board_member
Current Employees Featured
Dragan Cicic COO and CMO @ Actinium Pharmaceuticals
COO and CMO
Avinash Desai Chief Medical Officer @ Actinium Pharmaceuticals
Chief Medical Officer
2021-09-01
Paul Diamond Vice President, Patent and Legal Counsel @ Actinium Pharmaceuticals
Vice President, Patent and Legal Counsel
2021-09-01
Dale Ludwig Chief Scientific Officer @ Actinium Pharmaceuticals
Chief Scientific Officer
2018-01-01
Arun Swaminathan Chief Business and Commercial Officer @ Actinium Pharmaceuticals
Chief Business and Commercial Officer
2021-09-01
Caroline Yarbrough Chief Commercial Officer @ Actinium Pharmaceuticals
Chief Commercial Officer
2022-11-01
Sergio Traversa Interm-CEO @ Actinium Pharmaceuticals
Interm-CEO
Stock Details
Key Employee Changes
| Date | New article |
|---|---|
| 2022-11-02 | Actinium Appoints Seasoned Leader Caroline Yarbrough as Chief Commercial Officer to Spearhead Iomab-B Commercialization |
Official Site Inspections
http://www.actiniumpharmaceuticals.com
- Host name: 172.67.162.193
- IP address: 172.67.162.193
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Actinium Pharmaceuticals"
Actinium Pharmaceuticals - Crunchbase Company …
Actinium Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing therapies for life threatening diseases using its alpha particle …See details»
Profile - Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) is a publicly traded, late-stage biopharmaceutical company, leading the development of targeted radiotherapies to …See details»
Board of Directors - Actinium Pharmaceuticals, Inc. (ATNM)
She was a Vice President in the Clinical Safety Organization, chaired a PhRMA-FDA working group, and worked in the area of scientific licensing. She also led the development of …See details»
Investor Relations :: Actinium Pharmaceuticals, Inc. (ATNM)
Investor Relations Actinium Pharmaceuticals, Inc. 100 Park Avenue, 23rd Floor New York, NY 10017 Investorrelations@ actiniumpharma.comSee details»
Actinium Pharmaceuticals (ATNM) Company Profile & Description
3 days ago Company profile for Actinium Pharmaceuticals, Inc. (ATNM) stock, with a description, list of executives, contact details and other key facts.See details»
Org Chart Actinium Pharmaceuticals - The Official Board
The org chart of Actinium Pharmaceuticals contains its 18 main executives including Sandesh Seth, Steve O'Loughlin and Jenny Hsieh.See details»
About :: Actinium Pharmaceuticals, Inc. (ATNM)
Robust Pipeline Actinium Pharmaceuticals' drug development pipeline features Iomab-B with positive pivotal Phase 3 results, Iomab-ACT, which is intended to be a conditioning regimen …See details»
Actinium Pharmaceuticals, Inc. – (ATNM)
Actinium is developing a pipeline of Antibody Radiation Conjugates for targeted conditioning and combination therapies The Pivotal Phase 3 SIERRA Trial for Iomab-B is 100% Enrolled.See details»
Actinium Pharmaceuticals, Inc. - LinkedIn
Actinium Pharmaceuticals, Inc. | 13,451 followers on LinkedIn. Targeted Therapies for Patients with Unmet Needs | Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted ...See details»
Actinium Pharmaceuticals Inc - Company Profile - GlobalData
Actinium Pharmaceuticals Inc (Actinium) is a biopharmaceutical company focused on developing targeted radiotherapies for cancer patients with limited treatment options.See details»
Actinium Pharmaceuticals Company Profile | Management and
Actinium Pharmaceuticals Profile and History Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing ARCs or Antibody Radiation-Conjugates, which …See details»
Actinium Pharmaceuticals - Crunchbase Company Profile & Funding
Actinium Pharmaceuticals provides biopharmaceutical, radiotherapies, medical research, development, and clinical trial services.See details»
Actinium Pharmaceuticals, Inc. (Actinium Pharmaceuticals, Inc.)
The meeting provides a platform for sharing knowledge, fostering collaboration, and exploring new developments in diagnostic imaging, radionuclide therapies, and molecular medicine. About …See details»
Actinium Pharmaceuticals - Overview, News & Similar companies ...
View Actinium Pharmaceuticals (www.actiniumpharma.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Actinium Pharmaceuticals - Funding, Financials, Valuation
Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.See details»
Actinium Pharmaceuticals - Craft
Oct 29, 2024 Actinium Pharmaceuticals is a biopharmaceutical company developing targeted payload immunotherapeutics for the treatment of advanced cancers. Its targeted radiotherapy …See details»
Actinium Pharmaceuticals - Contacts, Employees, Board Members, …
Actinium Pharmaceuticals provides biopharmaceutical, radiotherapies, medical research, development, and clinical trial services.See details»
Actinium Expands Clinical Leadership Team to Support Key …
NEW YORK, Oct. 27, 2022 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, …See details»
Actinium Pharmaceuticals to Host KOL Investor Call at 8am ET …
3 days ago Actinium Pharmaceuticals, Inc. (Actinium or the Company), a pioneer in the development of targeted radiotherapies, will host an investor call at 8:00 am ET today that will …See details»
Actinium Pharmaceuticals Announces ATNM-400 a Novel Non …
1 day ago Actinium Pharmaceuticals, Inc. (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced ATNM-400, a novel, non-PSMA …See details»